Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiparametric Magnetic Resonance Imaging Features Identify Aggressive Prostate Cancer at the Phenotypic and Transcriptomic Level.
Beksac AT, Cumarasamy S, Falagario U, Xu P, Takhar M, Alshalalfa M, Gupta A, Prasad S, Martini A, Thulasidass H, Rai R, Berger M, Hectors S, Jordan J, Davicioni E, Nair S, Haines K 3rd, Lewis S, Rastinehad A, Yadav K, Jayaratna I, Taouli B, Tewari A. Beksac AT, et al. J Urol. 2018 Dec;200(6):1241-1249. doi: 10.1016/j.juro.2018.06.041. Epub 2018 Jul 3. J Urol. 2018. PMID: 30563651
External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension.
Heetman JG, van der Hoeven EJRJ, Rajwa P, Zattoni F, Kesch C, Shariat S, Dal Moro F, Novara G, La Bombara G, Sattin F, von Ostau N, Pötsch N, Baltzer PAT, Wever L, Van Basten JPA, Van Melick HHE, Van den Bergh RCN, Gandaglia G, Soeterik TFW; European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Heetman JG, et al. Prostate Cancer Prostatic Dis. 2023 Nov 6. doi: 10.1038/s41391-023-00738-3. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37932522
Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy.
Cormio L, Cindolo L, Troiano F, Marchioni M, Di Fino G, Mancini V, Falagario U, Selvaggio O, Sanguedolce F, Fortunato F, Schips L, Carrieri G. Cormio L, et al. Front Oncol. 2018 Oct 16;8:438. doi: 10.3389/fonc.2018.00438. eCollection 2018. Front Oncol. 2018. PMID: 30386737 Free PMC article.
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators.
Falagario UG, Martini A, Wajswol E, Treacy PJ, Ratnani P, Jambor I, Anastos H, Lewis S, Haines K, Cormio L, Carrieri G, Rastinehad AR, Wiklund P, Tewari A. Falagario UG, et al. Eur Urol Oncol. 2020 Oct;3(5):700-704. doi: 10.1016/j.euo.2019.08.015. Epub 2019 Sep 20. Eur Urol Oncol. 2020. PMID: 31548130
Staging Accuracy of Multiparametric Magnetic Resonance Imaging in Caucasian and African American Men Undergoing Radical Prostatectomy.
Falagario UG, Ratnani P, Lantz A, Jambor I, Dovey Z, Verma A, Treacy PJ, Sobotka S, Martini A, Bashorun H, Ashan M, Wagaskar VG, Lewis S, Cormio L, Carrieri G, Kyprianou N, Mohamed N, Tewari A. Falagario UG, et al. J Urol. 2020 Jul;204(1):82-90. doi: 10.1097/JU.0000000000000774. Epub 2020 Jan 24. J Urol. 2020. PMID: 31977261
120 results